The resultant in silico datasets ranged from one NY-ESO-1 TCR-transduced CD8+ T cell interaction (T cell killed) to one non-specific CD8+ T cell interaction (Alive), up to 1:100,000 T cell killed to Alive tumor cells, in multiple of 10 increments. The gene discussed is CD8A; the disease is neoplasm.